Sector valuations Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.390 USD | -0.88% |
|
-2.02% | +23.27% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -3.06x | 1.5x | 0.15x | 477.56x | -1.57x | -1.59x | -.--% | 387M | ||
| 34.44x | 4.37x | 1.49x | 6.06x | 18.73x | 25.99x | 0.95% | 49.42B | ||
| -23.76x | 18.68x | -0.69x | 347.84x | -22.47x | -21.75x | -.--% | 40.34B | ||
| 24.8x | 4.7x | 5.15x | 2.76x | 11.92x | 18.17x | -.--% | 34.01B | ||
| 46.22x | 6.76x | 0.29x | 4.56x | 29.13x | 34.41x | -.--% | 33.56B | ||
| 27.42x | 2.17x | 0.61x | 7.88x | 19.73x | 22.89x | 0.41% | 26.84B | ||
| 31.38x | 15.64x | 2.87x | 5.06x | 23.03x | 24.15x | -.--% | 15.19B | ||
| -23.54x | 348.82x | -0.46x | 15.34x | -22.95x | -22.05x | -.--% | 13.96B | ||
| 23.29x | 2.44x | 0.8x | 1.99x | 8.77x | 13.87x | 1.15% | 13.36B | ||
| 23.42x | 1.31x | 0.16x | 1.87x | 11.32x | 12.86x | -.--% | 12.68B | ||
| -33.4x | 10.13x | 1.37x | 127.92x | -36.41x | -63.36x | -.--% | 12B | ||
| 36.51x | 3.27x | -0.12x | 3.27x | 12.73x | 15.47x | -.--% | 10.79B | ||
| 60.91x | 5.1x | 0.4x | 9.1x | 25.83x | 28.24x | 0.45% | 11.06B | ||
| -28.67x | 25.38x | -0.69x | 6.86x | 168.32x | -527.84x | -.--% | 10.28B | ||
| -30.87x | 8.93x | -13.56x | 990.81x | -26.27x | -25.74x | -.--% | 9.99B | ||
| -32.41x | 8.34x | 7.15x | 95.32x | -21.39x | -20.62x | -.--% | 9.39B | ||
| -141.76x | 4.91x | 1.12x | 5.53x | 29.35x | 167.78x | -.--% | 9.05B | ||
| 35.77x | - | -0.12x | 16.53x | 29.51x | 31.97x | -.--% | 9.01B | ||
| -21.9x | 8.29x | -1.71x | 2562.65x | -18.58x | -17.65x | -.--% | 9.28B | ||
| Average | 0.25x | 26.71x | 0.22x | 246.78x | 12.57x | -16.04x | 0.16% | 17.4B | |
| Weighted average by Cap. | 9.75x | 22.81x | 0.71x | 156.80x | 11.60x | -3.98x | 0.24% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















